• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴刀豆球蛋白A刺激的人淋巴细胞产生的血管通透性因子的物理化学特性

Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.

作者信息

Sobel A T, Branellec A I, Blanc C J, Lagrue G A

出版信息

J Immunol. 1977 Oct;119(4):1230-4.

PMID:894032
Abstract

Stimulation of human lymphocytes with Con A resulted in the liberation of a soluble lymphokine that increased the permeability of guinea pig skin capillaries. This factor, termed vascular permeability factor (VPF), was characterized by physicochemical methods. Upon gel filtration chromatography on Sephadex G-100, it eluted in a narrow peak with an apparent molecular weight of 12,000 daltons. The sedimentation rate of VPF, estimated by sucrose density gradient ultracentrifugation, was 1.8 S. Polyacrylamide gel electrophoresis showed the biologic activity to migrate in the beta region; the factor displayed a pI of 6.4 upon isoelectric focusing. These characteristics allow VPF to be distinguished from other human lymphokines.

摘要

用刀豆蛋白A刺激人淋巴细胞会导致一种可溶性淋巴因子的释放,该因子可增加豚鼠皮肤毛细血管的通透性。这种被称为血管通透性因子(VPF)的因子通过物理化学方法进行了表征。在Sephadex G - 100上进行凝胶过滤色谱分析时,它以一个窄峰洗脱,表观分子量为12,000道尔顿。通过蔗糖密度梯度超速离心法估算,VPF的沉降速率为1.8 S。聚丙烯酰胺凝胶电泳显示其生物活性在β区域迁移;等电聚焦时该因子的等电点为6.4。这些特性使得VPF能够与其他人类淋巴因子区分开来。

相似文献

1
Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.伴刀豆球蛋白A刺激的人淋巴细胞产生的血管通透性因子的物理化学特性
J Immunol. 1977 Oct;119(4):1230-4.
2
Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.组胺受体阳性单核细胞的功能特性。I. 以组胺为配体选择性产生淋巴细胞趋化性淋巴因子。
J Immunol. 1983 Oct;131(4):1854-9.
3
A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.一种由淋巴细胞产生的血管通透性因子。I. 肾病综合征患者的验证。
Biomedicine. 1975 Feb 10;23(1):37-40.
4
Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.伴刀豆球蛋白A刺激的淋巴细胞上清液中的电荷减少淋巴细胞因子活性:初步生物学和生化特性分析
Biomed Biochim Acta. 1984;43(1):57-65.
5
Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.淋巴因子“皮肤反应因子”(SRF)与肾病综合征
Bibl Anat. 1975;13:331-4.
6
Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).伴刀豆球蛋白A刺激的人淋巴细胞对白细胞抑制因子的部分特性鉴定(LIF Con A)
J Immunol. 1975 Apr;114(4):1161-5.
7
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.一种由多种人类和啮齿动物肿瘤细胞系分泌的高度保守的血管通透性因子。
Cancer Res. 1986 Nov;46(11):5629-32.
8
[In vitro production of a human lymphokine by a specific mitogen in primary glomerular nephropathies].[原发性肾小球疾病中特定促细胞分裂剂对人淋巴因子的体外产生]
Ann Biol Clin (Paris). 1984;42(3):207-10.
9
Human leukocyte inhibitory factor (LIF): two distinct molecular species.
J Immunol. 1979 Mar;122(3):1059-61.
10
Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).局灶节段性肾小球硬化中肾小球通透因子(GPF)的研究以及GPF与血管通透因子(VPF)之间的关系。
Clin Nephrol. 1999 Nov;52(5):278-84.

引用本文的文献

1
Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood.免疫球蛋白E依赖性组胺释放因子在儿童特发性肾病综合征中的表达
Clin Exp Immunol. 2005 Oct;142(1):162-6. doi: 10.1111/j.1365-2249.2005.02890.x.
2
Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome.实验性肾病综合征中肾小球热休克蛋白27的表达改变
J Clin Invest. 1996 Jun 15;97(12):2697-704. doi: 10.1172/JCI118723.
3
The role of lymphokines in delayed-type hypersensitivity reactions.淋巴因子在迟发型超敏反应中的作用。
Springer Semin Immunopathol. 1984;7(4):321-46. doi: 10.1007/BF00201965.
4
Role of polyclonal cell activation in the initiation of immune complex-mediated pulmonary injury following antigen inhalation.多克隆细胞活化在抗原吸入后免疫复合物介导的肺损伤起始中的作用。
Environ Health Perspect. 1980 Apr;35:43-53. doi: 10.1289/ehp.803543.
5
Immunologic mechanisms of parenchymal lung injury.肺实质损伤的免疫机制。
Environ Health Perspect. 1984 Apr;55:239-57. doi: 10.1289/ehp.8455239.
6
Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome.微小病变型肾病中抗体依赖的细胞毒性降低。
Pediatr Nephrol. 1988 Apr;2(2):224-8. doi: 10.1007/BF00862595.
7
Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?循环因子在微小病变型肾病综合征的发病机制中起作用吗?
Pediatr Nephrol. 1989 Jul;3(3):341-9. doi: 10.1007/BF00858545.
8
Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice.
Cancer Immunol Immunother. 1989;28(4):267-74. doi: 10.1007/BF00205236.
9
Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome.微小病变型肾病综合征患者淋巴细胞上清液中血管通透性因子与白细胞介素-2的鉴别
Clin Exp Immunol. 1991 Oct;86(1):157-62. doi: 10.1111/j.1365-2249.1991.tb05789.x.
10
Phase I trial of FK973: description of a delayed vascular leak syndrome.FK973的I期试验:迟发性血管渗漏综合征的描述
Invest New Drugs. 1991 Nov;9(4):377-82. doi: 10.1007/BF00183587.